BCMU
MD icon

BlueCrest Capital Management (UK)’s Pediatrix Medical MD Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-81,875
Closed -$4.76M – 611
2014
Q2 		$4.76M Buy
+81,875
New +$4.82M 0.16% 92

Other funds holding MD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BlueCrest Capital Management (UK)'s MD Position: Q3 2014 in Review

BlueCrest Capital Management (UK) sold out of Pediatrix Medical (MD) in Q3 2014, closing a stake of 81,875 shares — an estimated $4.76M sold.

BlueCrest Capital Management (UK) first reported a position in MD in Q2 2014 and held it in 1 quarter. The position peaked at $4.76M in Q2 2014. 332 funds tracked by Wall St. Rank hold MD as of Q3 2014.

  • BlueCrest Capital Management (UK) reported no remaining Pediatrix Medical position as of Q3 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 81,875 Pediatrix Medical shares in Q3 2014, an estimated $4.76M.
  • BlueCrest Capital Management (UK) first reported a position in Pediatrix Medical in Q2 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Pediatrix Medical position peaked at $4.76M in Q2 2014.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.